Synergistically Anti-Multiple Myeloma Effects: Flavonoid, Non-Flavonoid Polyphenols, and Bortezomib

Multiple myeloma (MM) is a clonal plasma cell tumor originating from a post-mitotic lymphoid B-cell lineage. Bortezomib(BTZ), a first-generation protease inhibitor, has increased overall survival, progression-free survival, and remission rates in patients with MM since its clinical approval in 2003....

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Kaixi, Jiang, Wei, Jia, Huanan, Lei, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687375/
https://www.ncbi.nlm.nih.gov/pubmed/36358997
http://dx.doi.org/10.3390/biom12111647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687375/
https://www.ncbi.nlm.nih.gov/pubmed/36358997
http://dx.doi.org/10.3390/biom12111647

Ejemplares similares